Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.02
-0.79 (-8.10%)
Dec 17, 2025, 3:29 PM EST - Market open
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $76.8 million as of December 17, 2025. Its market cap has decreased by -64.85% in one year.
Market Cap
76.80M
Enterprise Value
-66.36M
1-Year Change
-64.85%
Ranking
Category
Stock Price
$9.02
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $76.80M, a decrease of -77.86%. That is a compound annual growth rate of -18.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 83.58M | -44.92% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | 987.90M | 288.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |